Avidity Partners Management LP Bio Atla, Inc. Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.3 - $8.25 $1.51 Million - $5.42 Million	-657,500 Reduced 52.18%	602,500 $1.61 Million
Q4 2022 Feb 14, 2023	BUY	$6.29 - $11.01 $7.93 Million - $13.9 Million	1,260,000 New	1,260,000 $10.4 Million
Q1 2021 May 17, 2021	SELL	$32.41 - $70.91 $1.62 Million - $3.55 Million	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$31.02 - $35.16 $1.55 Million - $1.76 Million	50,000 New	50,000 $1.7 Million

23.4M

30.8K

57K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $14.9M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.